Annual Operating Profit
-$63.22 M
-$41.93 M-196.87%
31 December 2023
Summary:
Verrica Pharmaceuticals annual operaing income is currently -$63.22 million, with the most recent change of -$41.93 million (-196.87%) on 31 December 2023. During the last 3 years, it has fallen by -$23.04 million (-57.34%). VRCA annual operating profit is now -3204.86% below its all-time high of -$1.91 million, reached on 31 December 2016.VRCA Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$20.70 M
-$5.50 M-36.16%
30 September 2024
Summary:
Verrica Pharmaceuticals quarterly operating income is currently -$20.70 million, with the most recent change of -$5.50 million (-36.16%) on 30 September 2024. Over the past year, it has increased by +$3.21 million (+13.43%). VRCA quarterly operating profit is now -1529.83% below its all-time high of $1.45 million, reached on 30 September 2022.VRCA Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$75.11 M
+$3.21 M+4.10%
30 September 2024
Summary:
Verrica Pharmaceuticals TTM operating income is currently -$75.11 million, with the most recent change of +$3.21 million (+4.10%) on 30 September 2024. Over the past year, it has dropped by -$26.27 million (-53.81%). VRCA TTM operating profit is now -13076.84% below its all-time high of -$570.00 thousand, reached on 31 March 2017.VRCA TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRCA Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -196.9% | +13.4% | -53.8% |
| 3 y3 years | -57.3% | -75.9% | -117.9% |
| 5 y5 years | -189.0% | -216.4% | -148.1% |
VRCA Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -196.9% | at low | -1529.8% | +13.4% | -258.1% | +4.1% |
| 5 y | 5 years | -196.9% | at low | -1529.8% | +13.4% | -258.1% | +4.1% |
| alltime | all time | -3204.9% | at low | -1529.8% | +13.4% | <-9999.0% | +4.1% |
Verrica Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$20.70 M(+36.2%) | -$75.11 M(-4.1%) |
| June 2024 | - | -$15.21 M(-18.2%) | -$78.32 M(+4.8%) |
| Mar 2024 | - | -$18.60 M(-9.7%) | -$74.73 M(+18.2%) |
| Dec 2023 | -$63.22 M(+196.9%) | -$20.60 M(-13.9%) | -$63.22 M(+29.5%) |
| Sept 2023 | - | -$23.92 M(+105.9%) | -$48.83 M(+108.1%) |
| June 2023 | - | -$11.62 M(+63.9%) | -$23.47 M(+11.9%) |
| Mar 2023 | - | -$7.09 M(+14.1%) | -$20.97 M(-1.5%) |
| Dec 2022 | -$21.30 M(-31.1%) | -$6.21 M(-528.9%) | -$21.29 M(-9.6%) |
| Sept 2022 | - | $1.45 M(-115.9%) | -$23.55 M(-35.9%) |
| June 2022 | - | -$9.12 M(+23.1%) | -$36.77 M(-4.2%) |
| Mar 2022 | - | -$7.41 M(-12.5%) | -$38.38 M(+24.2%) |
| Dec 2021 | -$30.91 M(-23.1%) | -$8.47 M(-28.0%) | -$30.91 M(-10.3%) |
| Sept 2021 | - | -$11.77 M(+9.7%) | -$34.47 M(+6.6%) |
| June 2021 | - | -$10.73 M(<-9900.0%) | -$32.34 M(+6.9%) |
| Mar 2021 | - | $60.00 K(-100.5%) | -$30.24 M(-24.7%) |
| Dec 2020 | -$40.18 M | -$12.03 M(+24.9%) | -$40.18 M(+11.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$9.64 M(+11.7%) | -$36.14 M(+9.4%) |
| June 2020 | - | -$8.63 M(-12.6%) | -$33.04 M(+3.5%) |
| Mar 2020 | - | -$9.88 M(+23.7%) | -$31.93 M(+6.2%) |
| Dec 2019 | -$30.08 M(+37.5%) | -$7.99 M(+22.1%) | -$30.08 M(-0.7%) |
| Sept 2019 | - | -$6.54 M(-13.0%) | -$30.28 M(+0.7%) |
| June 2019 | - | -$7.52 M(-6.3%) | -$30.07 M(+7.3%) |
| Mar 2019 | - | -$8.03 M(-2.0%) | -$28.02 M(+28.1%) |
| Dec 2018 | -$21.88 M(+390.9%) | -$8.19 M(+29.3%) | -$21.88 M(+44.7%) |
| Sept 2018 | - | -$6.33 M(+15.8%) | -$15.12 M(+49.0%) |
| June 2018 | - | -$5.47 M(+189.7%) | -$10.15 M(+75.8%) |
| Mar 2018 | - | -$1.89 M(+31.7%) | -$5.78 M(+29.6%) |
| Dec 2017 | -$4.46 M(+133.0%) | -$1.43 M(+5.6%) | -$4.46 M(+47.4%) |
| Sept 2017 | - | -$1.36 M(+24.0%) | -$3.02 M(+81.6%) |
| June 2017 | - | -$1.09 M(+92.1%) | -$1.67 M(+192.1%) |
| Mar 2017 | - | -$570.00 K | -$570.00 K |
| Dec 2016 | -$1.91 M | - | - |
FAQ
- What is Verrica Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals annual operating profit year-on-year change?
- What is Verrica Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals quarterly operating profit year-on-year change?
- What is Verrica Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals TTM operating profit year-on-year change?
What is Verrica Pharmaceuticals annual operaing income?
The current annual operating profit of VRCA is -$63.22 M
What is the all time high annual operating profit for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high annual operaing income is -$1.91 M
What is Verrica Pharmaceuticals annual operating profit year-on-year change?
Over the past year, VRCA annual operaing income has changed by -$41.93 M (-196.87%)
What is Verrica Pharmaceuticals quarterly operating income?
The current quarterly operating profit of VRCA is -$20.70 M
What is the all time high quarterly operating profit for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high quarterly operating income is $1.45 M
What is Verrica Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, VRCA quarterly operating income has changed by +$3.21 M (+13.43%)
What is Verrica Pharmaceuticals TTM operating income?
The current TTM operating profit of VRCA is -$75.11 M
What is the all time high TTM operating profit for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high TTM operating income is -$570.00 K
What is Verrica Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, VRCA TTM operating income has changed by -$26.27 M (-53.81%)